Completed PHASE2 INTERVENTIONAL 4-arm NCT00504231

Intradermal Influenza Vaccine Study in Elders

Intradermal vs. Intramuscular Delivery of Influenza Vaccine in Immunocompetent Elders

Sponsor: PATH

Conditions Influenza

Interventions Fluzone Influenza Vaccine (2007-2008)

Updated 6 times since 2017 Last updated: Jun 8, 2012 Started: Sep 30, 2007 Primary completion: Jan 31, 2008 Completion: Jan 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Influenza and is currently completed. PATH leads this study, which shows 6 recorded versions since 2007 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Sep 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

PATH
Seattle Institute for Biomedical and Clinical Research
VA Puget Sound Health Care System

Data source: PATH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.